The global intraoperative radiation therapy market size was estimated to be USD 55.8 million in 2023 and is expected to reach at USD 115.4 million by 2034 with a CAGR of 6.83% during the forecast period 2024-2034. Rising demand for highly efficient radiation therapy systems for cancer treatment, growing product approvals by regulatory bodies, increasing prevalence of cancer, surge in funding by major market players, rising number of IORT treatment procedures, growing research & development activities, surge in technological advancements, and increasing introduction of products capable of delivering intraoperative radiation therapy for cancer treatment are the key factors propelling the market expansion.
Increasing introduction of products capable of delivering intraoperative radiation therapy for cancer treatment is predicted to boost the market growth during the forecast period. The growth of the market is being propelled by the IORT treatment procedure, which enables the precise delivery of high doses of radiation directly into the tumor or consistently to the tumor bed following resection, using low-energy X-rays. IORT offers both the theoretical and practical capability to apply radiation with high local precision to areas of tumor involvement or surgical resection, in close collaboration with the surgeon. For instance, in March 2022, Zeiss Medical Technology, a prominent global player in the fields of microsurgery and ophthalmology, has introduced the Intrabeam 600 device in the Indian market for the treatment of breast cancer and the administration of Intraoperative Radiation Therapy (IORT). This device offers the most minimally invasive treatment choice for individuals diagnosed with early-stage breast cancer.
By type, product was the highest revenue-grossing segment in the global intraoperative radiation therapy market in 2023 owing to the increased accessibility, advancements in technologically sophisticated mobile equipment, progress in treatment planning, expanding utilization of IORT products in cancer treatment have contributed to this trend, and rising collaborations within market players. For instance, in July 2023, iCAD, Inc., a worldwide leader in innovative cancer detection and therapy solutions in the field of medical technology, has unveiled a new strategic multi-year commercial agreement with Radiology Partners, the largest radiology practice in the United States, inclusive of its owned and affiliated practices. Additionally, services is predicted to grow at fastest CAGR during the forecast period owing to the increasing development in technologies and growing introduction of advanced systems.
By method, electron IORT was the highest revenue-grossing segment in the global intraoperative radiation therapy market in 2023 as it is more precise, safer & positive outcomes associated with the IORT, increasing need for early diagnostics of various diseases, and rising launch of electron intraoperative radiotherapy systems. Additionally, intraoperative brachytherapy is predicted to grow at fastest CAGR during the forecast period owing to its effectiveness & shorter treatment time, rising prevalence of cancer such as prostate, breast, brain, head & neck, lung, uterine, vaginal, & other cancers, and surge in mergers & acquisitions within market players. For instance, in May 2022, Brainlab, which is a digital medical technology company, revealed the acquisition of medPhoton GmbH, a company based in Austria that generates and manufactures robotic imaging alternatives for image-guided radiation therapy and surgery. As a result of this partnership, the Loop-X mobile imaging robot has obtained marketing approval.
By application, breast cancer was the highest revenue-grossing segment in the global intraoperative radiation therapy market in 2023 owing to the increasing prevalence of breast cancer, rising adoption of intraoperative radiation therapy to detect or burn the breast tumor at a specific location, and growing investment by major market players. For instance, in October 2022, A Berlin-based startup named Vara has secured $4.5 million in funding to further its mission of offering data-driven breast cancer screening to the entire region. Through its AI-driven approach, this purpose-oriented startup partners with local clinics to grant women access to life-saving treatment and improve the efficiency of screening procedures. Additionally, lung cancer is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of lung cancer and surge in adoption of intraoperative radiation therapy to treat early-stage non-small cell lung tumors in locations that are easily accessible.
By end-user, hospitals was the highest revenue-grossing segment in the global intraoperative radiation therapy market in 2023 owing to the growing number of patient admissions, increasing cancer specialty hospitals, rising prevalence of cancer, surge in adoption of specialized equipment to deliver treatments in a controlled & safe manner by hospitals, and growing collaborations within market players. For instance, in June 2023, GE Healthcare has forged a distribution agreement with DePuy Synthes, aiming to expand the availability of GE Healthcare's OEC 3D Imaging System to a broader group of surgeons and patients throughout the United States. This collaboration combines GE Healthcare's advanced imaging technology with DePuy Synthes' extensive range of medical products. Additionally, ambulatory care services (ASCs) is predicted to grow at fastest CAGR during the forecast period owing to its cost-effectiveness & efficient alternative to a hospital's operating room, increasing preference by patients, growing demand for better pre-and post-operative care.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising well-established healthcare infrastructure, surge in research & development activities, growing prevalence of cancers, and increasing initiatives by leading market players. For instance, in March 2022, Sensus Healthcare, Inc., a medical device company specializing in efficient, non-invasive, minimally invasive, and affordable therapeutic solutions for both oncological and non-oncological ailments, has disclosed the sale of its SculpturaTM assets to Empyrean Medical Systems for a cash sum of $15 million. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing investment in research & development activities, growing healthcare expenditure, surge in prevalence of cancer, and rising adoption of advanced systems. For instance, in February 2022, Fortis Cancer Institute has unveiled Karnataka's inaugural Intraoperative radiotherapy (IORT) system for addressing breast cancer.
Increasing introduction of products capable of delivering intraoperative radiation therapy for cancer treatment is predicted to boost the market growth during the forecast period. The growth of the market is being propelled by the IORT treatment procedure, which enables the precise delivery of high doses of radiation directly into the tumor or consistently to the tumor bed following resection, using low-energy X-rays. IORT offers both the theoretical and practical capability to apply radiation with high local precision to areas of tumor involvement or surgical resection, in close collaboration with the surgeon. For instance, in March 2022, Zeiss Medical Technology, a prominent global player in the fields of microsurgery and ophthalmology, has introduced the Intrabeam 600 device in the Indian market for the treatment of breast cancer and the administration of Intraoperative Radiation Therapy (IORT). This device offers the most minimally invasive treatment choice for individuals diagnosed with early-stage breast cancer.
By type, product was the highest revenue-grossing segment in the global intraoperative radiation therapy market in 2023 owing to the increased accessibility, advancements in technologically sophisticated mobile equipment, progress in treatment planning, expanding utilization of IORT products in cancer treatment have contributed to this trend, and rising collaborations within market players. For instance, in July 2023, iCAD, Inc., a worldwide leader in innovative cancer detection and therapy solutions in the field of medical technology, has unveiled a new strategic multi-year commercial agreement with Radiology Partners, the largest radiology practice in the United States, inclusive of its owned and affiliated practices. Additionally, services is predicted to grow at fastest CAGR during the forecast period owing to the increasing development in technologies and growing introduction of advanced systems.
By method, electron IORT was the highest revenue-grossing segment in the global intraoperative radiation therapy market in 2023 as it is more precise, safer & positive outcomes associated with the IORT, increasing need for early diagnostics of various diseases, and rising launch of electron intraoperative radiotherapy systems. Additionally, intraoperative brachytherapy is predicted to grow at fastest CAGR during the forecast period owing to its effectiveness & shorter treatment time, rising prevalence of cancer such as prostate, breast, brain, head & neck, lung, uterine, vaginal, & other cancers, and surge in mergers & acquisitions within market players. For instance, in May 2022, Brainlab, which is a digital medical technology company, revealed the acquisition of medPhoton GmbH, a company based in Austria that generates and manufactures robotic imaging alternatives for image-guided radiation therapy and surgery. As a result of this partnership, the Loop-X mobile imaging robot has obtained marketing approval.
By application, breast cancer was the highest revenue-grossing segment in the global intraoperative radiation therapy market in 2023 owing to the increasing prevalence of breast cancer, rising adoption of intraoperative radiation therapy to detect or burn the breast tumor at a specific location, and growing investment by major market players. For instance, in October 2022, A Berlin-based startup named Vara has secured $4.5 million in funding to further its mission of offering data-driven breast cancer screening to the entire region. Through its AI-driven approach, this purpose-oriented startup partners with local clinics to grant women access to life-saving treatment and improve the efficiency of screening procedures. Additionally, lung cancer is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of lung cancer and surge in adoption of intraoperative radiation therapy to treat early-stage non-small cell lung tumors in locations that are easily accessible.
By end-user, hospitals was the highest revenue-grossing segment in the global intraoperative radiation therapy market in 2023 owing to the growing number of patient admissions, increasing cancer specialty hospitals, rising prevalence of cancer, surge in adoption of specialized equipment to deliver treatments in a controlled & safe manner by hospitals, and growing collaborations within market players. For instance, in June 2023, GE Healthcare has forged a distribution agreement with DePuy Synthes, aiming to expand the availability of GE Healthcare's OEC 3D Imaging System to a broader group of surgeons and patients throughout the United States. This collaboration combines GE Healthcare's advanced imaging technology with DePuy Synthes' extensive range of medical products. Additionally, ambulatory care services (ASCs) is predicted to grow at fastest CAGR during the forecast period owing to its cost-effectiveness & efficient alternative to a hospital's operating room, increasing preference by patients, growing demand for better pre-and post-operative care.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising well-established healthcare infrastructure, surge in research & development activities, growing prevalence of cancers, and increasing initiatives by leading market players. For instance, in March 2022, Sensus Healthcare, Inc., a medical device company specializing in efficient, non-invasive, minimally invasive, and affordable therapeutic solutions for both oncological and non-oncological ailments, has disclosed the sale of its SculpturaTM assets to Empyrean Medical Systems for a cash sum of $15 million. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing investment in research & development activities, growing healthcare expenditure, surge in prevalence of cancer, and rising adoption of advanced systems. For instance, in February 2022, Fortis Cancer Institute has unveiled Karnataka's inaugural Intraoperative radiotherapy (IORT) system for addressing breast cancer.
Segmentation: Intraoperative Radiation Therapy Market Report 2023 - 2034
Intraoperative Radiation Therapy Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Mn)
- Products
- Accessories
- Systems/Accelerators
- Treatment Planning Systems
- Applicators & Afterloaders
- Services
Intraoperative Radiation Therapy Market Analysis & Forecast by Method 2023 - 2034 (Revenue USD Mn)
- Intraoperative Brachytherapy
- Electron IORT
- Other
Intraoperative Radiation Therapy Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Mn)
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Brain Tumor
- Endometrial & Cervical Cancer
- Head and Neck Cancer
- Gastrointestinal Cancer
- Other
Intraoperative Radiation Therapy Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Mn)
- Ambulatory Care Services (Ascs)
- Hospitals
- Others
Intraoperative Radiation Therapy Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Mn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Intraoperative Radiation Therapy Market: Type Estimates & Trend Analysis
8. Intraoperative Radiation Therapy Market: Method Estimates & Trend Analysis
9. Intraoperative Radiation Therapy Market: Application Estimates & Trend Analysis
10. Intraoperative Radiation Therapy Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Intraoperative Radiation Therapy Market
13. Europe Global Intraoperative Radiation Therapy Market
14. Asia Pacific Global Intraoperative Radiation Therapy Market
15. Latin America Global Intraoperative Radiation Therapy Market
16. MEA Global Intraoperative Radiation Therapy Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- GMV Innovating Solutions
- Ariane Medical Systems Ltd
- ICAD Inc.
- Eckert & Ziegler
- Intraop Medical Corporation
- Elekta AB Inc.
- Varian Medical Systems Inc.
- Sensus Healthcare Inc.
- Isoray Inc.
- Sordina IORT Technologies
- Varian Medical Systems
- Carl Zeiss Meditec AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 55.8 Million |
| Forecasted Market Value ( USD | $ 115.4 Million |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
